In the latest session, Biotricity Inc (NASDAQ: BTCY) closed at $1.00 up 8.67% from its previous closing price of $0.92. In other words, the price has increased by $+0.0799 from its previous closing price. On the day, 1592484 shares were traded. BTCY stock price reached its highest trading level at $1.0300 during the session, while it also had its lowest trading level at $0.8030.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a deeper understanding of Biotricity Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.10 and its Current Ratio is at 0.21.
On March 07, 2022, Lake Street started tracking the stock assigning a Buy rating and target price of $5.
On November 23, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $6.H.C. Wainwright initiated its Buy rating on November 23, 2021, with a $6 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BTCY now has a Market Capitalization of 8.67M and an Enterprise Value of 32.20M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.81. Its current Enterprise Value per Revenue stands at 2.77 whereas that against EBITDA is -3.36.
Stock Price History:
Over the past 52 weeks, BTCY has reached a high of $5.10, while it has fallen to a 52-week low of $0.70. The 50-Day Moving Average of the stock is 1.0091, while the 200-Day Moving Average is calculated to be 1.4885.
Shares Statistics:
For the past three months, BTCY has traded an average of 30.96K shares per day and 49.08k over the past ten days. A total of 8.51M shares are outstanding, with a floating share count of 7.81M. Insiders hold about 17.10% of the company’s shares, while institutions hold 3.90% stake in the company. Shares short for BTCY as of Feb 15, 2024 were 93.88k with a Short Ratio of 3.03, compared to 125.43k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.00% and a Short% of Float of 1.17%.
Earnings Estimates
There are 1 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.43 for the current quarter, with a high estimate of -$0.43 and a low estimate of -$0.43, while EPS last year was -$0.54. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$1.73 and -$1.73 for the fiscal current year, implying an average EPS of -$1.73. EPS for the following year is -$0.55, with 1 analysts recommending between -$0.55 and -$0.55.
Revenue Estimates
A total of 1 analysts believe the company’s revenue will be $3.2M this quarter.It ranges from a high estimate of $3.2M to a low estimate of $3.2M. As of the current estimate, Biotricity Inc’s year-ago sales were $2.74M, an estimated increase of 16.70% from the year-ago figure.
A total of 1 analysts have provided revenue estimates for BTCY’s current fiscal year. The highest revenue estimate was $12.11M, while the lowest revenue estimate was $12.11M, resulting in an average revenue estimate of $12.11M. In the same quarter a year ago, actual revenue was $9.64M, up 25.60% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $14.3M in the next fiscal year. The high estimate is $14.3M and the low estimate is $14.3M. The average revenue growth estimate for next year is up 18.10% from the average revenue estimate for this year.
